Delivery Order SPE2DB22D3501-SPE2DB25FXB13
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Adapalene 0.1% Cream in 45-gram units, with a ceiling value of $2,134.71 and an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a continuation of the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Adapalene 0.1% Cream in 45-gram units, with a ceiling value of $1,241.06 and a firm fixed price structure. This non-set-aside contract is set for completion by August 15, 2025, and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,252.49 to AmerisourceBergen Drug Corp for the supply of Adapalene 0.1% Cream in 45-gram quantities. This firm fixed-price contract, awarded on August 13, 2025, represents a non-set-aside, competitively awarded procurement action with an ultimate completion date of August 14, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, serving as the place of performance. This delivery order is...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $5,044.01 to AmerisourceBergen Drug Corp for Adapalene 0.1% cream on August 27, 2025, with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 20, 2025, for Adapalene 0.1% Cream in 45-gram quantities. The contract is valued at $1,423.93 under a firm fixed price structure with an ultimate completion date of August 21, 2025. This award represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $6,294.97 firm fixed price delivery order to AmerisourceBergen Drug Corp for Adapalene 0.3% Gel in 45-gram quantities. The contract, which was competitively awarded with no set-aside designation, became effective on July 31, 2025, with an ultimate completion date of August 1, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $8,429.12 to Amerisourcebergen Drug Corporation for the provision of 4561562916 ! ADAPALENE 0.1% CREAM 45GM. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is short, spanning from July 21, 2023 through July 24, 2023. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this order to supply the...
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4,557,605,012 units of Adapalene 0.1% cream, 45 grams, at a total ceiling value of $19,220.60. The contract is a firm fixed price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 45 gram tubes of 0.1% Adapalene cream. The contract has a ceiling value of $2,059.58 and a completion date of August 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables the government to efficiently...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,870.15 firm fixed-price order is for the supply of Adapalene 0.1% cream, a topical acne medication. The contract has an ultimate completion date of September 20, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXB13Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Adapalene 0.1% Cream in 45-gram units, with a ceiling value of $4,509.24. This is a firm fixed price, non-set-aside competitively awarded contract with an ultimate completion date of August 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's extensive pharmaceutical supply relationship with the Defense Logistics Agency Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems worldwide. The company's portfolio demonstrates expertise across multiple therapeutic domains, enabling it to fulfill diverse pharmaceutical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 8/27/25 |